Integral Health Asset Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

$859 Million
Q1 2025

A detailed history of Integral Health Asset Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 50,000 shares of ALNY stock, worth $16.5 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

50,000

Previous 45,000 11.11%

Holding current value

$16.5 Million

Previous $10.6 Million 27.51%

% of portfolio

1.57%

Previous 0.95%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$233.07 - $290.7 $1.17 Million - $1.45 Million	5,000 Added 11.11%	50,000 $13.5 Million
Q4 2024 Feb 14, 2025	BUY	$232.27 - $300.43 $4.65 Million - $6.01 Million	20,000 Added 80.0%	45,000 $10.6 Million
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $5.85 Million - $7.18 Million	25,000 New	25,000 $6.88 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $732,550 - $991,000	5,000 Added 11.11%	50,000 $7.47 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $6.81 Million - $8.85 Million	45,000 New	45,000 $8.61 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $5.92 Million - $6.79 Million	32,000 Added 160.0%	52,000 $9.88 Million
Q1 2023 May 09, 2023	SELL	$182.66 - $235.53 $2.74 Million - $3.53 Million	-15,000 Reduced 42.86%	20,000 $4.01 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $6.49 Million - $8.45 Million	-35,000 Reduced 50.0%	35,000 $8.32 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $3.19 Million - $5.34 Million	23,034 Added 49.04%	70,000 $14 Million
Q2 2022 Aug 03, 2022	BUY	$120.42 - $169.29 $5.66 Million - $7.95 Million	46,966 New	46,966 $6.85 Million
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $2.54 Million - $3.48 Million	-20,000 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$159.56 - $209.29 $797,800 - $1.05 Million	-5,000 Reduced 20.0%	20,000 $3.39 Million
Q2 2021 Aug 30, 2021	SELL	$128.63 - $176.89 $3.22 Million - $4.42 Million	-25,000 Reduced 50.0%	25,000 $4.24 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $1.29 Million - $1.77 Million	10,000 Added 25.0%	50,000 $8.48 Million
Q1 2021 May 10, 2021	BUY	$126.83 - $175.69 $3.17 Million - $4.39 Million	25,000 Added 166.67%	40,000 $5.65 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $1.23 Million - $1.47 Million	-10,000 Reduced 40.0%	15,000 $1.95 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $3.03 Million - $4.14 Million	25,000 New	25,000 $3.64 Million

Others Institutions Holding ALNY

# of Institutions

727

Shares Held

111M

Call Options Held

966K

Put Options Held

853K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $40.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account

Integral Health Asset Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History